Blood markers of fatty acids and vitamin D, cardiovascular measures, body mass index, and physical activity relate to longitudinal cortical thinning in normal aging

Neurobiology of Aging
Kristine B WalhovdAnders M Fjell

Abstract

We hypothesized that higher levels of omega-3 fatty acids, vitamin D, and physical activity relate to cortical sparing, whereas higher levels of cholesterol, systolic blood pressure, and body mass index (BMI) relate to increased atrophy in the adult lifespan. Longitudinal measures of cortical thickness were derived from magnetic resonance imaging scans acquired (mean interval 3.6 years) from 203 healthy persons aged 23-87 years. At follow-up, measures of BMI, blood pressure, and physical activity were obtained. Blood levels of docosahexaenoic acid, eicosapentaenoic acid, vitamin D, and cholesterol were measured in a subsample (n = 92). Effects were tested in cortical surface-based analyses, with sex, age, follow-up interval, and the interactions between each included as covariates. Higher levels of docosahexaenoic acid, vitamin D, and physical activity related to cortical sparing. Higher cholesterol and BMI related to increased cortical thinning. Effects were independent, did not interact with age, and the cholesterol effect was restricted to males. Eicosapentaenoic acid and blood pressure showed no effects. The observed effects show promise for potential factors to reduce cortical atrophy in normal aging.

References

Feb 22, 1974·Nature·T C Stamp, J M Round
Dec 10, 1997·Annals of Neurology·S KalmijnM M Breteler
Jun 9, 1998·IEEE Transactions on Medical Imaging·J G SledA C Evans
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·B Fischl, A M Dale
Mar 20, 2001·Archives of Neurology·D LaurinK Rockwood
May 8, 2002·The Journal of Clinical Endocrinology and Metabolism·Prema B RapuriVera Haynatzka
Dec 25, 2002·Neurology·M J EngelhartM M B Breteler
Dec 5, 2003·Cerebral Cortex·Bruce FischlAnders M Dale
Dec 20, 2003·NeuroImage·Satoru Hayasaka, Thomas E Nichols
May 19, 2004·Archives of Neurology·Christiane ReitzRichard Mayeux
Oct 12, 2005·Archives of Neurology·Miia KivipeltoAulikki Nissinen
Mar 21, 2006·NeuroImage·Nicola PannacciulliPietro A Tataranni
Aug 24, 2006·Public Health Nutrition·Maria HagströmerMichael Sjöström
Aug 31, 2006·Gerontology·Tesseki KinSatoshi Ueno
Sep 5, 2006·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Robert K McNamara, Susan E Carlson
Dec 15, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Stanley J ColcombeArthur F Kramer
Apr 7, 2007·Annals of the New York Academy of Sciences·Naftali RazE Mark Haacke
Jan 20, 2009·Cerebral Cortex·Anders M FjellKristine B Walhovd
May 29, 2009·The American Journal of Clinical Nutrition·Elizabeth E DevoreMonique M B Breteler
Jul 3, 2009·Neurobiology of Aging·Kristine B WalhovdAnders M Fjell
Dec 19, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Tommy Cederholm, Jan Palmblad
Apr 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·April J HoUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 20, 2010·NeuroImage·Martin ReuterBruce Fischl
Sep 2, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Milan ChangLenore J Launer
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kirk I EricksonArthur F Kramer
Feb 26, 2011·NeuroImage·Wesley K ThompsonUNKNOWN Alzheimer's Disease Neuroimaging Initiative

❮ Previous
Next ❯

Citations

Mar 15, 2016·Neurobiology of Aging·Shahrzad Kharabian MasoulehAnja Veronica Witte
Nov 14, 2015·American Journal of Hypertension·Timothy M Hughes, Kaycee M Sink
Jan 9, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Dienke J BosPaul A M Smeets
Dec 10, 2015·Nutrition Research Reviews·Jim M MontiNeal J Cohen
Apr 14, 2016·Cerebral Cortex·Anders M FjellKristine B Walhovd
Jul 28, 2016·Neurobiology of Aging·Ekaterina TchistiakovaUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 5, 2016·Frontiers in Neuroscience·Marta K Zamroziewicz, Aron K Barbey
Nov 2, 2014·Science·Ulman Lindenberger
May 12, 2016·PloS One·Thomas J LittlejohnsDavid J Llewellyn
Aug 21, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Gro O NygaardHanne F Harbo
Jan 20, 2018·Annual Review of Food Science and Technology·Fereidoon Shahidi, Priyatharini Ambigaipalan
Dec 20, 2017·Journal of Alzheimer's Disease : JAD·Prabha SiddarthDavid A Merrill
Sep 1, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Shahrzad Kharabian MasoulehA Veronica Witte
Sep 17, 2014·Current Opinion in Clinical Nutrition and Metabolic Care·Elske M Brouwer-Brolsma, Lisette C P G M de Groot
Feb 17, 2018·European Psychiatry : the Journal of the Association of European Psychiatrists·Kristine B WalhovdUNKNOWN Lifebrain Consortium
Mar 7, 2020·Cerebral Cortex·Anders M FjellUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Nov 12, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·K B WalhovdUNKNOWN for Lifebrain Consortium
Feb 27, 2020·Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition·Anne Cecilie Sjøli BråthenKristine B Walhovd
Jun 27, 2020·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Cassidy M FifordJosephine Barnes
Aug 21, 2019·Frontiers in Aging Neuroscience·Frauke BeyerA Veronica Witte
Sep 26, 2020·Frontiers in Human Neuroscience·Frida BergmanCarl-Johan Boraxbekk
Sep 15, 2020·Frontiers in Public Health·Isabelle Budin-LjøsneLarysa Zasiekina
Jul 13, 2017·Journal of Alzheimer's Disease : JAD·Catherine C PriceFrederic T Billings
Feb 8, 2021·NeuroImage·Julia BinnewiesBrenda W J H Penninx
Oct 23, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Aline ThomasCécilia Samieri
May 23, 2017·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Robert K McNamaraRobert Krikorian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.